GITR controls intestinal inflammation by suppressing IL-15-dependent NK cell activity.
Sakurai T, Okuyama Y, Kobayashi S, Phung HT, Asao A, Kawabe T, Ndhlovu LC, Riccardi C, Kudo H, Wada M, Nio M, So T, Ishii N.
Sakurai T, et al. Among authors: nio m.
FASEB J. 2020 Nov;34(11):14820-14831. doi: 10.1096/fj.202001675R. Epub 2020 Sep 10.
FASEB J. 2020.
PMID: 32910505